Global Bronchiectasis Treatment Market Size, Status and Forecast 2019-2025

  • receipt Report ID : 11061
  • calendar_today Published On: Feb, 2020
  • file_copy Pages: 165
  • list Pharmaceuticals and Healthcare

Bronchiectasis refers to a condition characterized by damaged airways (tubes) and affect their ability to clear out the mucus. This deposition of mucus leads to bacterial infections and hence resulting in serious and repeated lung infections. Bronchiectasis is a long term condition resulting in serious health conditions such as heart failure and respiratory failure. Mucus producing cough is the major symptom of this condition. Bad breath, wheezing chest and recurrent lung infections are some of the other symptoms witnessed by bronchiectasis patients. Occurrence of this condition is more prominent in children. Pneumonia along with cystic fibrosis, immune deficiency and others are known to cause bronchiectasis. Blood tests, chest x-ray, CT scan and spirometry are some of the diagnostic methodologies employed to determine this condition.

The major factors driving the growth of the market are consistent rise in the patients suffering from respiratory ailments, technological advances and increased participation of the market players in research and development. On the contrary, lack of specificity in treatment, strict regulatory policies and high costs involved in research and development are some of the factors that might restrain the growth of the market.

In 2018, the global Bronchiectasis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Bronchiectasis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Bronchiectasis Treatment development in United States, Europe and China.

The key players covered in this study

AstraZeneca

Aradigm Corporation

Fisher & Paykel Healthcare Corporation

Zambon

...

Market segment by Type, the product can be split into

Amikacin Sulfate

ARD-3150

CHF-6333

Ciprofloxacin Hydrochloride

Doxofylline

Others

Market segment by Application, split into

Clinic

Hospital

Homecare

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

The study objectives of this report are:

To analyze global Bronchiectasis Treatment status, future forecast, growth opportunity, key market and key players.

To present the Bronchiectasis Treatment development in United States, Europe and China.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Bronchiectasis Treatment are as follows:

History Year: 2014-2018

Base Year: 2018

Estimated Year: 2019

Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered

1.4 Market Analysis by Type

1.4.1 Global Bronchiectasis Treatment Market Size Growth Rate by Type (2014-2025)

1.4.2 Amikacin Sulfate

1.4.3 ARD-3150

1.4.4 CHF-6333

1.4.5 Ciprofloxacin Hydrochloride

1.4.6 Doxofylline

1.4.7 Others

1.5 Market by Application

1.5.1 Global Bronchiectasis Treatment Market Share by Application (2014-2025)

1.5.2 Clinic

1.5.3 Hospital

1.5.4 Homecare

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Bronchiectasis Treatment Market Size

2.2 Bronchiectasis Treatment Growth Trends by Regions

2.2.1 Bronchiectasis Treatment Market Size by Regions (2014-2025)

2.2.2 Bronchiectasis Treatment Market Share by Regions (2014-2019)

2.3 Industry Trends

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Opportunities

3 Market Share by Key Players

3.1 Bronchiectasis Treatment Market Size by Manufacturers

3.1.1 Global Bronchiectasis Treatment Revenue by Manufacturers (2014-2019)

3.1.2 Global Bronchiectasis Treatment Revenue Market Share by Manufacturers (2014-2019)

3.1.3 Global Bronchiectasis Treatment Market Concentration Ratio (CR5 and HHI)

3.2 Bronchiectasis Treatment Key Players Head office and Area Served

3.3 Key Players Bronchiectasis Treatment Product/Solution/Service

3.4 Date of Enter into Bronchiectasis Treatment Market

3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

4.1 Global Bronchiectasis Treatment Market Size by Type (2014-2019)

4.2 Global Bronchiectasis Treatment Market Size by Application (2014-2019)

5 United States

5.1 United States Bronchiectasis Treatment Market Size (2014-2019)

5.2 Bronchiectasis Treatment Key Players in United States

5.3 United States Bronchiectasis Treatment Market Size by Type

5.4 United States Bronchiectasis Treatment Market Size by Application

6 Europe

6.1 Europe Bronchiectasis Treatment Market Size (2014-2019)

6.2 Bronchiectasis Treatment Key Players in Europe

6.3 Europe Bronchiectasis Treatment Market Size by Type

6.4 Europe Bronchiectasis Treatment Market Size by Application

7 China

7.1 China Bronchiectasis Treatment Market Size (2014-2019)

7.2 Bronchiectasis Treatment Key Players in China

7.3 China Bronchiectasis Treatment Market Size by Type

7.4 China Bronchiectasis Treatment Market Size by Application

8 Japan

8.1 Japan Bronchiectasis Treatment Market Size (2014-2019)

8.2 Bronchiectasis Treatment Key Players in Japan

8.3 Japan Bronchiectasis Treatment Market Size by Type

8.4 Japan Bronchiectasis Treatment Market Size by Application

9 Southeast Asia

9.1 Southeast Asia Bronchiectasis Treatment Market Size (2014-2019)

9.2 Bronchiectasis Treatment Key Players in Southeast Asia

9.3 Southeast Asia Bronchiectasis Treatment Market Size by Type

9.4 Southeast Asia Bronchiectasis Treatment Market Size by Application

10 India

10.1 India Bronchiectasis Treatment Market Size (2014-2019)

10.2 Bronchiectasis Treatment Key Players in India

10.3 India Bronchiectasis Treatment Market Size by Type

10.4 India Bronchiectasis Treatment Market Size by Application

11 Central & South America

11.1 Central & South America Bronchiectasis Treatment Market Size (2014-2019)

11.2 Bronchiectasis Treatment Key Players in Central & South America

11.3 Central & South America Bronchiectasis Treatment Market Size by Type

11.4 Central & South America Bronchiectasis Treatment Market Size by Application

12 International Players Profiles

12.1 AstraZeneca

12.1.1 AstraZeneca Company Details

12.1.2 Company Description and Business Overview

12.1.3 Bronchiectasis Treatment Introduction

12.1.4 AstraZeneca Revenue in Bronchiectasis Treatment Business (2014-2019)

12.1.5 AstraZeneca Recent Development

12.2 Aradigm Corporation

12.2.1 Aradigm Corporation Company Details

12.2.2 Company Description and Business Overview

12.2.3 Bronchiectasis Treatment Introduction

12.2.4 Aradigm Corporation Revenue in Bronchiectasis Treatment Business (2014-2019)

12.2.5 Aradigm Corporation Recent Development

12.3 Fisher & Paykel Healthcare Corporation

12.3.1 Fisher & Paykel Healthcare Corporation Company Details

12.3.2 Company Description and Business Overview

12.3.3 Bronchiectasis Treatment Introduction

12.3.4 Fisher & Paykel Healthcare Corporation Revenue in Bronchiectasis Treatment Business (2014-2019)

12.3.5 Fisher & Paykel Healthcare Corporation Recent Development

12.4 Zambon

12.4.1 Zambon Company Details

12.4.2 Company Description and Business Overview

12.4.3 Bronchiectasis Treatment Introduction

12.4.4 Zambon Revenue in Bronchiectasis Treatment Business (2014-2019)

12.4.5 Zambon Recent Development

13 Market Forecast 2019-2025

13.1 Market Size Forecast by Regions

13.2 United States

13.3 Europe

13.4 China

13.5 Japan

13.6 Southeast Asia

13.7 India

13.8 Central & South America

13.9 Market Size Forecast by Product (2019-2025)

13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Disclaimer

15.3 Author Details

List of Tables and Figures

Table Bronchiectasis Treatment Key Market Segments

Table Key Players Bronchiectasis Treatment Covered

Table Global Bronchiectasis Treatment Market Size Growth R

Please fill the form below, to recieve the report sample


+1